Cancer resistance as an acquired and inheritable trait

Janne Koch1, Jann Hau2, Henrik Elvang Jensen3

  • 1Department of Experimental Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark Institute of Veterinary Pathology, Faculty of LIFE Sciences, University of Copenhagen, Frederiksberg, Denmark jako@sund.ku.dk.

Anticancer Research
|November 5, 2014
PubMed
Abstract

Insights

Researchers induced cancer resistance in mice, finding it inheritable to offspring for at least two generations. This heritable induced cancer resistance (HICR) phenomenon, observed with S180 cells, offers a novel insight into acquired immunity.

Area of Science:

  • Immunology
  • Genetics
  • Cancer Biology

Background:

  • Acquired resistance to cancer is a significant challenge in oncology.
  • Investigating mechanisms of inherited immunity could offer new therapeutic avenues.

Purpose of the Study:

  • To induce cancer resistance in mice and determine if it is heritable.
  • To characterize the spectrum and immunological basis of this inherited resistance.

Main Methods:

  • BALB/c mice were immunized with inactivated S180 cancer cells (frozen/thawed, irradiated, or cell-free ascitic fluid).
  • Progeny of immunized mice were assessed for cancer resistance.
  • Flow cytometry (FACS) analyzed peritoneal cell populations.

Main Results:

  • Induced cancer resistance was inheritable to offspring for at least two generations, termed heritable induced cancer resistance (HICR).
  • Resistance was only observed with S180 cell-derived materials, not other cell lines.
  • Resistant mice showed an increased fraction of macrophages and no signs of cancer.

Conclusions:

  • Heritable induced cancer resistance (HICR) is demonstrable and inheritable from S180 cell immunization.
  • The molecular basis is unknown but may involve epigenetic modifications.
  • This study presents the first evidence of acquired, inherited cancer resistance.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

3.8K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.5K
Cancer Prevention02:59

Cancer Prevention

2.6K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.2K